Found 650 matching trials
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer PHASE3 This was a national, multi-center, open-label, phase IIIb trial to determin...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients N/A Breast cancer is one of the most common cancers in women. 20-30 % of all br...
Show More Location
Klinikum rechts der Isar der TU München, Klinik und Poliklinik für Frauenheilkunde
Learn More & Join Trial
500mg Fulvestrant Versus Exemestane in MBC N/A 500mg Fulvestrant versus Exemestane in MBC...
Learn More & Join Trial
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection PHASE3 This study is a randomized, open-label, multicentric, phase III trial condu...
Show More Location
Centre Hospitalier Universitaire
Learn More & Join Trial
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer PHASE3 POLAR is a phase III clinical trial, which will test the safety and efficac...
Show More Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer) PHASE2 This Phase II, randomized, open-label, multicenter study will evaluate the ...
Show More Status
Active Not Recruiting
Location
Northwest Georgia Oncology Centers PC - Marietta
Learn More & Join Trial
Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer PHASE2 The purpose of this study is to determine if the combination of endocrine t...
Show More Location
Cross Cancer Institute
Learn More & Join Trial
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy NA To explore the efficacy and safety of Chidamide combined with endocrine for...
Show More Learn More & Join Trial
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer PHASE3 The purpose of this open-label, multicenter, phase IIIb, single-arm study i...
Show More Location
Central Alabama Research
Learn More & Join Trial
Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy N/A Although randomized controlled trials (RCTs) provide evidence of efficacy, ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial